• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Role of optimal control theory in cancer chemotherapy.

作者信息

Swan G W

出版信息

Math Biosci. 1990 Oct;101(2):237-84. doi: 10.1016/0025-5564(90)90021-p.

DOI:10.1016/0025-5564(90)90021-p
PMID:2134485
Abstract

This paper presents a review of the ways in which optimal control theory interacts with cancer chemotherapy. There are three broad areas of investigation. One involves miscellaneous growth kinetic models, the second involves cell cycle models, and the third is a classification of "other models." Both normal and tumor cell populations are included in a number of the models. The concepts of deterministic optimal control theory are applied to each model in such a way as to present a cohesive picture. There are applications to both experimental and clinical tumors. Suggestions for designing better chemotherapy strategies are presented.

摘要

相似文献

1
Role of optimal control theory in cancer chemotherapy.
Math Biosci. 1990 Oct;101(2):237-84. doi: 10.1016/0025-5564(90)90021-p.
2
Development of optimal drug administration strategies for cancer-chemotherapy in the framework of systems theory.
Int J Biomed Comput. 1984 Mar-Apr;15(2):139-50. doi: 10.1016/0020-7101(84)90026-6.
3
Chemotherapeutic treatments involving drug resistance and level of normal cells as a criterion of toxicity.以耐药性和正常细胞水平作为毒性标准的化疗治疗。
Math Biosci. 1995 Feb;125(2):211-28. doi: 10.1016/0025-5564(94)00028-x.
4
Optimal drug regimens in cancer chemotherapy for single drugs that block progression through the cell cycle.癌症化疗中用于阻断细胞周期进展的单一药物的最佳用药方案。
Math Biosci. 1994 Oct;123(2):183-213. doi: 10.1016/0025-5564(94)90011-6.
5
A mathematical model of drug resistance: heterogeneous tumors.耐药性的数学模型:异质性肿瘤
Math Biosci. 1998 Jan 1;147(1):41-61. doi: 10.1016/s0025-5564(97)00080-1.
6
Drug kinetics and drug resistance in optimal chemotherapy.最佳化疗中的药物动力学与耐药性
Math Biosci. 1995 Feb;125(2):191-209. doi: 10.1016/0025-5564(94)00027-w.
7
General applications of optimal control theory in cancer chemotherapy.
IMA J Math Appl Med Biol. 1988;5(4):303-16. doi: 10.1093/imammb/5.4.303.
8
Conflicting objectives in chemotherapy with drug resistance.化疗中耐药性带来的目标冲突。
Bull Math Biol. 1997 Jul;59(4):707-24. doi: 10.1007/BF02458426.
9
Mathematic models for cancer chemotherapy: pharmacokinetic and cell kinetic considerations.癌症化疗的数学模型:药代动力学和细胞动力学考量
Cancer Chemother Rep. 1975 Jul-Aug;59(4):827-42.
10
Optimal chemotherapy: a case study with drug resistance, saturation effect, and toxicity.最佳化疗:一个关于耐药性、饱和效应和毒性的案例研究。
IMA J Math Appl Med Biol. 1994;11(1):45-59. doi: 10.1093/imammb/11.1.45.

引用本文的文献

1
Tumor microenvironment governs the prognostic landscape of immunotherapy for head and neck squamous cell carcinoma: A computational model-guided analysis.肿瘤微环境决定头颈部鳞状细胞癌免疫治疗的预后格局:一项计算模型引导的分析
PLoS Comput Biol. 2025 Jun 3;21(6):e1013127. doi: 10.1371/journal.pcbi.1013127. eCollection 2025 Jun.
2
Tumor microenvironment governs the prognostic landscape of immunotherapy for head and neck squamous cell carcinoma: A computational model-guided analysis.肿瘤微环境决定头颈部鳞状细胞癌免疫治疗的预后格局:一项计算模型引导的分析
bioRxiv. 2024 Sep 27:2024.09.26.615149. doi: 10.1101/2024.09.26.615149.
3
Phenotypic deconvolution in heterogeneous cancer cell populations using drug-screening data.
使用药物筛选数据对异质癌细胞群体进行表型推断。
Cell Rep Methods. 2023 Mar 6;3(3):100417. doi: 10.1016/j.crmeth.2023.100417. eCollection 2023 Mar 27.
4
Genetic, individual, and familial risk correlates of brain network controllability in major depressive disorder.遗传、个体和家族风险与重度抑郁症中脑网络可控性的相关性。
Mol Psychiatry. 2023 Mar;28(3):1057-1063. doi: 10.1038/s41380-022-01936-6. Epub 2023 Jan 13.
5
Personalized Immunotherapy Treatment Strategies for a Dynamical System of Chronic Myelogenous Leukemia.慢性粒细胞白血病动态系统的个性化免疫治疗策略
Cancers (Basel). 2021 Apr 22;13(9):2030. doi: 10.3390/cancers13092030.
6
Optimum multi-drug regime for compartment model of tumour: cell-cycle-specific dynamics in the presence of resistance.最优多药物疗法治疗肿瘤隔室模型:存在耐药性时细胞周期特异性动力学。
J Pharmacokinet Pharmacodyn. 2021 Aug;48(4):543-562. doi: 10.1007/s10928-021-09749-w. Epub 2021 Mar 22.
7
Control Theory and Cancer Chemotherapy: How They Interact.控制理论与癌症化疗:它们如何相互作用。
Front Bioeng Biotechnol. 2021 Jan 14;8:621269. doi: 10.3389/fbioe.2020.621269. eCollection 2020.
8
Optimal control to reach eco-evolutionary stability in metastatic castrate-resistant prostate cancer.最优控制以达到转移性去势抵抗性前列腺癌的生态进化稳定。
PLoS One. 2020 Dec 8;15(12):e0243386. doi: 10.1371/journal.pone.0243386. eCollection 2020.
9
The Evolution and Ecology of Resistance in Cancer Therapy.癌症治疗中耐药性的演变和生态学。
Cold Spring Harb Perspect Med. 2020 Nov 2;10(11):a040972. doi: 10.1101/cshperspect.a040972.
10
Pseudo-spectral method for controlling the drug dosage in cancer.用于控制癌症药物剂量的伪谱法。
IET Syst Biol. 2020 Oct;14(5):261-270. doi: 10.1049/iet-syb.2020.0054.